Lamotrigine Tablet, Chewable
Product Images NDC 68462-229

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 68462-229). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure2

A Kaplan-Meier survival curve chart comparing failure probability (%) over weeks for Lamotrigine versus placebo. The y-axis shows failure probability from 0% to 100%, and the x-axis displays time in weeks up to 80. The graph includes censored data points and labels for both Lamotrigine and placebo curves.*

FDA Label Image

Label25mg100s

Lamotrigine Tablets for Oral Suspension, chewable and dispersible tablets, 25 mg strength. The label indicates 100 tablets per container, distributed by Glenmark Pharmaceuticals Inc., USA, and manufactured by Glenmark Pharmaceuticals Ltd., India. The label includes storage instructions, cautions, and the National Drug Code (NDC) 68462-229-01.*

FDA Label Image

Label5mg100s

Lamotrigine 5 mg chewable dispersible tablets for oral suspension in a 100-tablet package. The label includes dispensing instructions for pharmacists, storage conditions, and manufacturer information, Glenmark Pharmaceuticals Inc., USA. The NDC is 68462-228-01.*

FDA Label Image

Logo

FDA Label Image

Sturcture

Chemical structure of lamotrigine, showing the arrangement of its nitrogen-containing heterocyclic rings and two chlorine-substituted benzene rings.*

FDA Label Image

Tablet25mg

Stamped pill markings on a chewable tablet of Lamotrigine. One side features the number '229' inside an oval, and the other side features the letter 'G' inside an oval. The image corresponds to oral chewable tablets available in strengths of 25 mg or 5 mg by Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Tablet5mg

Lamotrigine 25 mg chewable tablet imprint side showing '228' and the scored side for oral administration. The tablet is oblong and white. Labeler is Glenmark Pharmaceuticals Inc., USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.